home / stock / swkh / swkh news


SWKH News and Press, SWK Holdings Corporation From 12/27/21

Stock Information

Company Name: SWK Holdings Corporation
Stock Symbol: SWKH
Market: OTC
Website: swkhold.com

Menu

SWKH SWKH Quote SWKH Short SWKH News SWKH Articles SWKH Message Board
Get SWKH Alerts

News, Short Squeeze, Breakout and More Instantly...

SWKH - Biotricity on the rise after announcing $12M debt financing

Biotricity (BTCY +7.3%) is trading higher after the company announced the completion of a $12M non-convertible debt financing provided by SWK Funding LLC (NASDAQ:SWKH). Per the contractual terms, the health tech company will have an initial interest-only period of two years extendable to thre...

SWKH - Enteris BioPharma to Participate in Biotech Showcase Virtual and BIO Partnering at JPM During "J.P. Morgan Week 2022"

Enteris BioPharma to Participate in Biotech Showcase Virtual and BIO Partnering at JPM During "J.P. Morgan Week 2022" PR Newswire BOONTON, N.J. , Dec. 20, 2021 /PRNewswire/ -- Enteris BioPharma, Inc. , a biotechnology company developing innovative drug produc...

SWKH - SWK Holdings' Subsidiary, Enteris BioPharma, Receives $5 Million Milestone Payment from Cara Therapeutics

SWK Holdings' Subsidiary, Enteris BioPharma, Receives $5 Million Milestone Payment from Cara Therapeutics Fourth milestone payment triggered by successful completion of process technology transfer related to the development of Oral KORSUVA™ PR Newswire D...

SWKH - SWK Holdings confirms non-binding proposal from Carlson Capital for $19 per share

On November 23, 2021, SWK Holdings Corporation (NASDAQ:SWKH) says it received a non-binding proposal from Carlson Capital, L.P. to acquire all shares of SWK not already owned by Carlson for a price of $19.00 per share, payable in cash. The offer price represents an ~4.7% premium over SWK...

SWKH - Enteris BioPharma Publishes Article Examining the Growing Utilization of the 505(b)(2) Regulatory Pathway in Drug Development

Enteris BioPharma Publishes Article Examining the Growing Utilization of the 505(b)(2) Regulatory Pathway in Drug Development Paper Discusses the 505(b)(2) Pathway as a Vehicle for Innovation and Product Differentiation PR Newswire BOONTON, N.J. , Nov. 17, 2021...

SWKH - SWK Holdings Inc. (SWKH) CEO Winston Black on Q3 2021 Results - Earnings Call Transcript

SWK Holdings Inc. (SWKH) Q3 2021 Results Conference Call November 15, 2021 10:00 AM ET Company Participants Winston Black - Chairman, CEO Jason Rando - Tiberend Strategic Advisors Conference Call Participants Kyle Bauser - Colliers Securities Michael Diana - Maxim group Presentation Operator ...

SWKH - SWK Holdings EPS misses by $0.24, beats on revenue

SWK Holdings (NASDAQ:SWKH): Q3 GAAP EPS of $0.17 misses by $0.24. Revenue of $9.56M (-10.2% Y/Y) beats by $0.91M. Press Release For further details see: SWK Holdings EPS misses by $0.24, beats on revenue

SWKH - SWK Holdings Corporation Announces Financial Results for Third Quarter 2021

SWK Holdings Corporation Announces Financial Results for Third Quarter 2021 Conference Call and Live Audio Webcast Scheduled for Monday, November 15, 2021 at 10:00 a.m. ET PR Newswire DALLAS , Nov. 12, 2021 /PRNewswire/ -- Corporate Updates ...

SWKH - SWK Holdings Announces Strategic Plan to Focus on Core Specialty Finance Business

SWK Holdings Announces Strategic Plan to Focus on Core Specialty Finance Business Commitment to focus on and grow SWK's core specialty finance business going forward - The Company will pursue opportunities to optimize its capital structure with additional leverage to enhance...

SWKH - Enteris BioPharma to Participate in the Partnership Opportunities in Drug Delivery (PODD) 2021 Conference

Enteris BioPharma to Participate in the Partnership Opportunities in Drug Delivery (PODD) 2021 Conference PR Newswire BOONTON, N.J. , Oct. 26, 2021 /PRNewswire/ -- Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products based on...

Previous 10 Next 10